A patient with type 2 diabetes presents with increased fatigue, blurred vision, and tingling in her feet. Her recent diagnostic tests indicate poor glycemic control, elevated LDL cholesterol, and signs of diabetic nephropathy and neuropathy. Based on these findings, which nursing intervention is the highest priority to address her condition?

B) Collaborate with the healthcare provider to adjust her medication regimen to improve glycemic control.

A) Educate the patient on the importance of daily foot inspections to prevent neuropathic ulcers.

B) Collaborate with the healthcare provider to adjust her medication regimen to improve glycemic control.

C) Refer the patient to a dietitian for a nutritional assessment and meal planning.

D) Schedule regular ophthalmologic examinations to monitor diabetic retinopathy progression.

A patient with type 2 diabetes presents with increased fatigue, blurred vision, and tingling in the feet. Diagnostic results indicate poor glycemic control, elevated LDL cholesterol, positive urine microalbumin, and signs of diabetic retinopathy and peripheral neuropathy. Which nursing intervention is most appropriate to prioritize for this patient to prevent further complications?

B) Advise the patient to increase physical activity to improve insulin sensitivity.

A) Educate the patient on proper foot care to prevent injuries.

B) Advise the patient to increase physical activity to improve insulin sensitivity.

C) Recommend a diet low in saturated fats to address hyperlipidemia.

D) Schedule regular ophthalmologic exams to monitor diabetic retinopathy.

A patient with type 2 diabetes and hypertension has been on a revised treatment plan including a GLP-1 receptor agonist, dietary modifications, and increased physical activity. Despite these changes, the patient presents with worsening symptoms and increased microalbumin levels. What is the most appropriate initial nursing action to address the patient's current condition?

B) Collaborate with the healthcare provider to reassess the medication regimen for possible adjustments.

A) Educate the patient on the importance of strict dietary adherence to control blood glucose and blood pressure.

B) Collaborate with the healthcare provider to reassess the medication regimen for possible adjustments.

C) Schedule a follow-up appointment with a dietitian to reinforce dietary modifications.

D) Initiate a daily log for the patient to monitor blood pressure and blood glucose levels at home.

A patient with type 2 diabetes and hypertension has been placed on a GLP-1 receptor agonist and advised on lifestyle modifications. She returns with worsening symptoms, increased dizziness, and persistent fatigue. Her blood pressure is 150/95 mmHg, heart rate is 88 bpm, and fasting blood glucose is 172 mg/dL. Repeat urinalysis shows increased microalbumin levels. Which of the following nursing interventions is the most appropriate to address the patient's current condition?

D) Refer the patient to a nephrologist for further evaluation of her renal function.

A) Educate the patient on the importance of medication adherence and schedule regular follow-ups.

B) Increase the dosage of her antihypertensive medication to better control her blood pressure.

C) Recommend a low-sodium diet to help manage her blood pressure and fluid retention.

D) Refer the patient to a nephrologist for further evaluation of her renal function.

A patient with stage 3a chronic kidney disease and a history of type 2 diabetes is experiencing worsening fatigue, poor sleep quality, and gastrointestinal side effects from her GLP-1 receptor agonist. Given her current condition and laboratory results, which nursing intervention should be prioritized to address her immediate health concerns?

A) Educate the patient on the importance of medication adherence despite side effects.

B) Refer the patient to a nephrologist for specialized kidney management.

C) Initiate a discussion about introducing an SGLT2 inhibitor to improve renal outcomes.

D) Provide strategies to manage anxiety and improve sleep quality.

A 58-year-old female patient with type 2 diabetes mellitus presents with symptoms of fatigue, pallor, and poor sleep quality. She has been experiencing gastrointestinal side effects from her GLP-1 receptor agonist, leading to occasional missed doses. Her serum creatinine level is 1.5 mg/dL, and her eGFR is 55 mL/min/1.73 m². Her current treatment includes antihypertensives and statins, but her LDL cholesterol remains elevated. Which nursing intervention is most appropriate to prioritize for this patient?

A) Educate the patient on the importance of medication adherence to prevent progression of her kidney disease

B) Recommend starting a low-protein diet to decrease kidney workload

C) Suggest using over-the-counter sleep aids to improve sleep quality

D) Encourage the patient to increase her physical activity to improve her lipid profile

A patient with diabetic nephropathy presents with pitting edema, elevated blood pressure, and increased proteinuria. The healthcare team decides to introduce an SGLT2 inhibitor. What is the primary reason for selecting this medication in managing her condition?

B) To decrease glucose reabsorption in the kidneys, reducing hyperglycemia and offering renal protection

A) To directly reduce blood pressure by vasodilation

B) To decrease glucose reabsorption in the kidneys, reducing hyperglycemia and offering renal protection

C) To increase insulin secretion from the pancreas

D) To act as a diuretic, directly reducing fluid overload

A patient with diabetic nephropathy and recent cardiovascular complications is experiencing persistent pitting edema and elevated blood pressure despite adherence to her antihypertensive regimen. Which interdisciplinary intervention is most critical to prioritize in addressing her current condition?

A) Initiating a low-sodium diet to help reduce fluid retention.

B) Referring the patient to a cardiologist for evaluation of her cardiovascular health.

D) Scheduling regular counseling sessions to manage stress and anxiety.

A patient with type 2 diabetes and hypertension has been started on an SGLT2 inhibitor and presents with increased urination frequency, occasional dizziness, and a slight decline in eGFR. Which nursing intervention is most appropriate to address these symptoms while considering the patient's renal function?

B) Monitor blood pressure and hold antihypertensive medication if systolic <100 mmHg

A) Encourage increased fluid intake to prevent dehydration

B) Monitor blood pressure and hold antihypertensive medication if systolic <100 mmHg

C) Advise the patient to reduce physical activity to prevent dizziness

D) Recommend a high-protein diet to improve kidney function

A patient with type 2 diabetes and chronic kidney disease has been started on an SGLT2 inhibitor. She reports increased urination and occasional dizziness. Her blood pressure is 142/88 mmHg, and her eGFR is 55 mL/min/1.73 m². Which nursing intervention is the most appropriate to address the patient's current symptoms?

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Recommend the patient reduce fluid intake to manage increased urination.

C) Advise the patient to take diuretics at bedtime to minimize dizziness.

D) Suggest the patient increase dietary protein to improve kidney function.

diabetes type 2 - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance occurs when cells in muscles, fat, and liver do not respond effectively to insulin, leading to decreased glucose uptake and increased blood glucose levels. The pancreas compensates by producing more insulin, but over time, it cannot maintain this response.

• Secondary mechanism: Beta-cell dysfunction in the pancreas results in inadequate insulin secretion relative to the body's needs. Chronic hyperglycemia and increased demand on beta-cells lead to their progressive decline, exacerbating hyperglycemia.

• Key complication: Persistent high blood glucose levels can cause microvascular complications like retinopathy, nephropathy, and neuropathy, as well as macrovascular complications including cardiovascular disease, highlighting the importance of early intervention and glycemic control.

Patient Profile

Demographics:

58-year-old female, accountant

History:

• Key past medical history: Diagnosed with type 2 diabetes 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg once daily, Atorvastatin 20 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and blurred vision

• Key symptoms: Tingling sensation in feet, frequent urination, increased thirst

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 18 breaths/min, temperature 98.6°F, BMI 32 kg/m²

Section 1

New Diagnostic Results:

Following the patient's presentation with increased fatigue, blurred vision, and tingling in her feet, a series of diagnostic tests were conducted to assess the current state of her diabetes management and identify potential complications. Her HbA1c level returned at 9.2%, indicating poor glycemic control over the past three months. A comprehensive metabolic panel revealed elevated fasting blood glucose at 165 mg/dL, and her lipid profile showed elevated LDL cholesterol at 140 mg/dL, further underscoring the need for better management of her hyperlipidemia. Additionally, her urine microalbumin test was positive, suggesting early signs of diabetic nephropathy, reflecting kidney damage due to prolonged hyperglycemia.

The ophthalmologic examination revealed mild non-proliferative diabetic retinopathy, characterized by microaneurysms and small retinal hemorrhages. This finding aligns with her complaint of blurred vision and signifies the onset of microvascular complications from uncontrolled diabetes. An electromyography (EMG) study was performed to evaluate the tingling sensation in her feet, revealing peripheral neuropathy, a common complication of chronic hyperglycemia that affects nerve function.

These results indicate that the patient's type 2 diabetes is progressing with moderate complications, necessitating a review and adjustment of her current treatment regimen. The findings highlight the need for intensified glycemic control, potentially through the addition of another antidiabetic agent or lifestyle interventions. It also emphasizes the importance of regular monitoring and management of her hypertension and hyperlipidemia to reduce the risk of further macrovascular complications. The healthcare team will need to discuss these results with the patient, educating her on the significance of these complications and collaboratively developing a plan to address her condition more effectively.

Section 2

Change in Patient Status:

Following the diagnostic results and subsequent discussions with the healthcare team, the patient was placed on a revised treatment plan that included the addition of a GLP-1 receptor agonist to her medication regimen to improve glycemic control and aid in weight management. She was also advised to incorporate lifestyle changes, such as dietary modifications and increased physical activity, aimed at addressing her hyperlipidemia and hypertension. Despite these interventions, the patient returned to the clinic four weeks later with worsening symptoms, including increased episodes of dizziness and persistent fatigue.

Upon re-evaluation, her vital signs showed a blood pressure of 150/95 mmHg and a heart rate of 88 beats per minute. Her weight remained stable, but her fasting blood glucose was 172 mg/dL, indicating little improvement in her glycemic control. Additionally, repeat urinalysis showed a further increase in microalbumin levels, suggesting progression of her diabetic nephropathy. The patient also reported experiencing more frequent episodes of nocturia and mild swelling in her lower extremities, raising concerns about her renal function.

These findings suggest that her condition may be deteriorating despite the recent adjustments in her treatment plan. This necessitates a deeper exploration of potential underlying factors that may be contributing to the lack of progress, such as medication non-adherence, dietary indiscretions, or other undiagnosed comorbidities. The healthcare team will need to engage in a thorough clinical reasoning process to reassess her treatment strategy, consider the potential need for further diagnostic tests, and explore additional therapeutic options to prevent further complications and improve her overall health status.

Section 3

Change in Patient Status:

In light of the patient's worsening symptoms and the recent findings, the healthcare team decided to conduct a more comprehensive assessment to understand the underlying causes of her deteriorating condition. During this assessment, it was noted that the patient appeared more fatigued than on previous visits, with dark circles under her eyes and a noticeably pallid complexion. Upon further questioning, she admitted to feeling anxious and overwhelmed by her health challenges, which had led to poor sleep quality and occasional missed doses of her medication, particularly the GLP-1 receptor agonist, due to gastrointestinal side effects such as nausea.

To assess the full extent of her renal involvement, a serum creatinine test was conducted, revealing a level of 1.5 mg/dL, up from her baseline of 1.2 mg/dL, indicating a decline in kidney function. Her estimated glomerular filtration rate (eGFR) was calculated at 55 mL/min/1.73 m², confirming stage 3a chronic kidney disease. These findings were concerning, as they suggested that her diabetic nephropathy might be progressing despite efforts to manage her hyperglycemia and hypertension. Additionally, her lipid profile showed elevated LDL cholesterol at 140 mg/dL, with HDL cholesterol remaining low at 38 mg/dL, further complicating her cardiovascular risk profile.

Given these developments, the healthcare team recognized the urgent need to address the multifactorial issues contributing to her current status. This included reinforcing the importance of medication adherence, considering adjustments to her current pharmacotherapy to minimize side effects, and providing additional support to help her manage stress and improve sleep quality. Nutritional counseling and a referral to a nephrologist for specialized management of her kidney disease were also deemed necessary steps to prevent further complications. As the team deliberated on these strategies, they also considered the potential need for more aggressive interventions, such as the introduction of an SGLT2 inhibitor, to provide renal and cardiovascular benefits while maintaining better glycemic control.

Section 4

New Complications:

A few weeks after the interventions were implemented, the patient returned for a follow-up appointment, presenting with new symptoms that prompted concern among the healthcare team. She reported persistent swelling in her lower extremities, particularly around her ankles and feet, which had become increasingly uncomfortable and made walking difficult. Upon examination, pitting edema was observed bilaterally. Her blood pressure was noted to be slightly elevated at 148/92 mmHg, despite adherence to her antihypertensive regimen. These findings suggested possible fluid retention and worsening cardiovascular complications, potentially linked to her underlying kidney dysfunction.

Further laboratory tests were ordered to explore these new developments. Her urine protein-to-creatinine ratio had increased to 1.5 mg/mg, indicating significant proteinuria and suggesting further progression of diabetic nephropathy. Additionally, her hemoglobin A1c had risen to 8.2%, reflecting suboptimal glycemic control, likely exacerbated by the recent stress and medication adherence issues. Given these results, the healthcare team was concerned about the increased risk of chronic kidney disease progression and cardiovascular events.

In response, the team decided to optimize her treatment plan by introducing an SGLT2 inhibitor, aiming to provide both renal and cardiovascular protection while improving her glycemic control. The patient was also referred to a cardiologist to evaluate her cardiovascular health and explore potential adjustments in her antihypertensive therapy. A multidisciplinary approach involving a dietitian and a mental health counselor was recommended to address her nutritional needs and provide support for managing anxiety and stress. These steps were intended to stabilize her condition and prevent further complications, while empowering the patient to take an active role in her health management.

Section 5

Several weeks after the adjustments to her treatment plan were implemented, the patient returned for another follow-up appointment. During this visit, she expressed feeling slightly more energetic and reported a mild reduction in the swelling of her lower extremities since the introduction of the SGLT2 inhibitor. However, she noticed that her urination frequency had increased. Upon examination, her vital signs revealed a blood pressure of 142/88 mmHg, showing a slight improvement, but still above the target range. Her weight had decreased by 3 pounds, suggesting some resolution of fluid retention. However, she mentioned experiencing occasional dizziness, which raised concerns about potential orthostatic hypotension, possibly linked to her new medication or dehydration.

The recent laboratory results provided a mixed picture. The hemoglobin A1c had decreased to 7.9%, indicating a marginal improvement in glycemic control, while the urine protein-to-creatinine ratio remained unchanged at 1.5 mg/mg. Her estimated glomerular filtration rate (eGFR) was calculated at 55 mL/min/1.73 m², showing a slight decline from previous measurements, which reinforced the need for careful monitoring of renal function. Additionally, serum electrolytes revealed a sodium level at the lower end of normal at 135 mmol/L, indicating a potential side effect of the SGLT2 inhibitor.

Based on these findings, the healthcare team discussed the importance of maintaining adequate hydration and monitoring her blood pressure closely. They considered adjusting her antihypertensive regimen to better manage her blood pressure without exacerbating her renal condition. The cardiologist recommended a low-dose diuretic to address the fluid overload, with careful observation for any further electrolyte imbalances. The interdisciplinary team emphasized lifestyle modifications, such as a low-sodium diet and regular physical activity, to support cardiovascular health. By addressing these new challenges, the team aimed to stabilize the patient's condition and minimize the risk of further complications, highlighting the importance of ongoing monitoring and patient engagement in her care plan.